EFFECTIVENESS, TOLERABILITY AND COMPLIANCE OF SCHIZOPHRENIC PATIENTS UNDER TREATMENT WITH ORAL ATYPICAL ANTIPSYCHOTICS OR LONG-ACTING INJECTABLE RISPERIDONE IN DAILY ROUTINE
European Psychiatry(2010)
Abstract
Conclusions The trend of these data towards lower relapse rates and longer retention with RLAI vs. oSGA indicates that RLAI therapy may help patients effectively to achieve better long-term outcomes.
MoreTranslated text
Key words
oral atypical antipsychotics,schizophrenic patients,long-acting
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined